We are live on ! Find out more
BIOL

Biolase, Inc.
BIOL

Delisted

BIOL was delisted on the 18th of June, 2024.

Back to rankings

28 hedge funds and large institutions have $17.8M invested in Biolase, Inc. in 2017 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 3

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

13% less funds holding

Funds holding: 32 → 28 (-4)

35% less capital invested

Capital invested by funds: $27.5M → $17.8M (-$9.72M)

50% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 6

Holders
28
Holders Change
-4
Holders Change %
-12.5%
% of All Funds
0.7%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
5
Reduced
3
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
OIM
Oracle Investment Management
Connecticut
+$2.55M
2
Citadel Advisors
Citadel Advisors
Florida
+$34.5K
3
VF
Virtu Financial
New York
+$34.5K
4
TSS
Two Sigma Securities
New York
+$25.9K
5
TMC
Trellus Management Company
Florida
+$17.2K

Top Sellers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
-$1.12M
2
GIP
Granite Investment Partners
California
-$924K
3
Vanguard Group
Vanguard Group
Pennsylvania
-$155K
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$139K
5
PCMI
Princeton Capital Management Inc
New Jersey
-$68.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
IA
26
IFP Advisors
Florida
$6K – – –
WS
27
Wedbush Securities
California
$6K – – –
Wells Fargo
28
Wells Fargo
California
$6K – – –
LTFS
29
Ladenburg Thalmann Financial Services
Florida
$2K – – –
Bank of America
30
Bank of America
North Carolina
$1K – – –
Royal Bank of Canada
31
Royal Bank of Canada
Ontario, Canada
$1K – – –
FDCDDQ
32
Federation des caisses Desjardins du Quebec
Quebec, Canada
$1 – – –
CCM
33
Consonance Capital Management
New York
– -$1.12M -92 Closed
GIP
34
Granite Investment Partners
California
– -$924K -76 Closed
D.E. Shaw & Co
35
D.E. Shaw & Co
New York
– -$139K -11 Closed
Deutsche Bank
36
Deutsche Bank
Germany
– -$51.7K -6 Closed
Susquehanna International Group
37
Susquehanna International Group
Pennsylvania
– -$49K -4 Closed
Commonwealth Equity Services
38
Commonwealth Equity Services
Massachusetts
– -$12K -1 Closed
Creative Planning
39
Creative Planning
Kansas
– -$5K – –
Manulife (Manufacturers Life Insurance)
40
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$1K – –
1
2

BIOL Hedge Fund Activity: Q3 2017 in Review

28 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Biolase, Inc. (BIOL) for Q3 2017, worth a combined $17.8M — down 35% from $27.5M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of BIOL and 3 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 5 added.

The largest buyer was Oracle Investment Management, adding an estimated $2.55M. The largest seller was Consonance Capital Management, exiting entirely with an estimated $1.12M sold.

  • 28 institutional investors held Biolase, Inc. (BIOL) as of Q3 2017, down from 32 in Q2 2017.
  • Funds reported $17.8M of Biolase, Inc. stock for Q3 2017, down 35% quarter-over-quarter.
  • 3 funds opened new Biolase, Inc. positions in Q3 2017 and 6 closed out, a net change of -3 holders.
  • The largest Biolase, Inc. buyer in Q3 2017 was Oracle Investment Management, an estimated $2.55M added.
  • The largest Biolase, Inc. seller in Q3 2017 was Consonance Capital Management, an estimated $1.12M sold.

Based on aggregated 13F filings for Q3 2017.